Answers are grounded in this paper and cite their sources.
Summary Three consecutive-day injections with different doses (0.1, 0.25, 0.5, 1.0, 2.0 and 4.0 μg/g) of estradiol-17β (E2) produced statistically significant increases in the cytosolic NADP-linked malate dehydrogenase and glucose-6-phosphate dehydrogenase activities in the ovary of the freshwater prawn (Macrobrachium rosenbergii) on the 4th day of treatment over the control values, depending upon the doses administered. Dose-dependent increases in the malate dehydrogenase and glucose-6-phosphate dehydrogenase activities were observed between 0.1–0.25, 0.25–0.5, and 0.5–1.0 μg/g doses. A similar magnitude of response was found at 1.0, 2.0 and 4.0 μg/g dose in both the cases of malate dehydrogenase and glucose-6-phosphate dehydrogenase activities. A lower dose of 0.5 μg/g was ineffective in eliciting any response to either enzyme. Ergosterol (2.0 μg/g) did not evoke any change in the malate dehydrogenase and glucose-6-phosphate dehydrogenase activities in comparison to the control values. Simultaneous injection of tamoxifen (0.5 μg/g) with E2 (2.0 μg/g) caused an inhibition of the E2-induced rise in the glucose-6-phosphate dehydrogenase activity but failed to show similar changes in the case of malate dehydrogenase activity. Use of cycloheximide (0.5 mg/l of immersion medium) also inhibited E2 (2.0 μg/g)-stimulated increase in the activities of these two enzymes. The data clearly show a subcellular action of estrogen with an indication of its role in lipogenesis in the ovary of the freshwater prawn.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: